Martin Wygod Biography and Net Worth

Director of Forian

Founder of Forian, Inc. and Medical Outcomes Research Analysis LLC, Max C. Wygod is Executive Chairman at Forian, Inc. and Executive Chairman at Medical Outcomes Research Analysis LLC (a subsidiary of Forian, Inc.).

He previously was Vice President-Business Development of WebMD Health Corp.

Max C. Wygod received an undergraduate degree from Duke University and an MBA from The Leonard N Stern School of Business.

What is Martin J. Wygod's net worth?: The estimated net worth of Martin J. Wygod is at least $128,077.32 as of October 4th, 2023. Mr. Wygod owns 62,783 shares of Forian stock worth more than $128,077 as of November 2nd. This net worth approximation does not reflect any other assets that Mr. Wygod may own. Learn More about Martin J. Wygod's net worth.
How do I contact Martin J. Wygod?: The corporate mailing address for Mr. Wygod and other Forian executives is 41 University Drive, Suite 400, Newtown, PA 18940, United States. Forian can also be reached via phone at +17203285372. Learn More on Martin J. Wygod's contact information.
Has Martin J. Wygod been buying or selling shares of Forian?: Martin J. Wygod has not been actively trading shares of Forian during the last ninety days. Most recently, on Wednesday, October 4th, Martin J. Wygod bought 1,700 shares of Forian stock. The stock was acquired at an average cost of $2.38 per share, with a total value of $4,046.00. Following the completion of the transaction, the director now directly owns 62,783 shares of the company's stock, valued at $149,423.54. Learn More on Martin J. Wygod's trading history.
Who are Forian's active insiders?: Forian's insider roster includes Jennifer Hajj (Director), Stanley Trotman, Jr. (Director), and Martin Wygod (Director). Learn More on Forian's active insiders.

Martin J. Wygod Insider Trading History at Forian

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/4/2023	Buy	1,700	$2.38	$4,046.00	62,783
5/30/2023	Buy	4,565	$2.39	$10,910.35	56,294
5/25/2023	Buy	3,000	$2.34	$7,020.00	51,729
5/23/2023	Buy	5,999	$2.38	$14,277.62	47,402
5/18/2023	Buy	5,444	$2.29	$12,466.76	41,403
2/14/2023	Buy	10,485	$3.91	$40,996.35	35,959
4/13/2022	Buy	2,030	$4.67	$9,480.10	22,324
4/11/2022	Buy	3,059	$5.02	$15,356.18	14,261
4/6/2022	Buy	202	$5.41	$1,092.82	11,202
4/4/2022	Buy	3,000	$6.46	$19,380.00	3,000
4/1/2022	Buy	6,827	$6.68	$45,604.36
3/30/2022	Buy	800	$6.75	$5,400.00
3/28/2022	Buy	3,200	$6.41	$20,512.00
2/14/2022	Buy	4,800	$7.66	$36,768.00
2/10/2022	Buy	4,800	$7.92	$38,016.00
1/21/2022	Buy	1,600	$8.01	$12,816.00
1/10/2022	Buy	3,200	$7.81	$24,992.00
12/15/2021	Buy	1,654	$7.81	$12,917.74
12/13/2021	Buy	6,678	$7.94	$53,023.32
12/10/2021	Buy	30	$8.04	$241.20
12/6/2021	Buy	6	$8.14	$48.84
12/3/2021	Buy	8,000	$8.10	$64,800.00
11/22/2021	Buy	455	$9.20	$4,186.00
11/17/2021	Buy	4,811	$9.83	$47,292.13
10/14/2021	Buy	9,002	$10.04	$90,380.08
10/5/2021	Buy	700	$10.08	$7,056.00
9/15/2021	Buy	7,844	$9.94	$77,969.36
9/13/2021	Buy	4,000	$10.00	$40,000.00
6/1/2021	Buy	1,300	$9.95	$12,935.00
5/25/2021	Buy	6,414	$9.97	$63,947.58
5/21/2021	Buy	8,000	$9.95	$79,600.00
5/19/2021	Buy	5,000	$9.94	$49,700.00

Martin J. Wygod Buying and Selling Activity at Forian

Forian Company Overview

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

Today's Range

Now: $2.04

$2.04

$2.10

50 Day Range

MA: $2.21

$2.04

$2.53

2 Week Range

Now: $2.04

$2.00

$4.15

Volume

23,878 shs

Average Volume

15,890 shs

Market Capitalization

$63.47 million

P/E Ratio

40.80

Dividend Yield

N/A

Beta

1.09

Banking failure dead ahead

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.